Skip to main content
Olatunji Alese, MD, Oncology, Atlanta, GA

OlatunjiAleseMDFWACS

Oncology Atlanta, GA

Gastrointestinal Cancer

Associate Professor, Winship Cancer Institute of Emory University

Dr. Alese is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Alese's full profile

Already have an account?

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Westchester Medical Center
    Westchester Medical CenterResidency, Internal Medicine, 2009 - 2012
  • University of Ibadan
    University of IbadanClass of 2000

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2013 - 2025
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Skilled Hands Award
  • ASCO International Development and Education Award
  • Bethune Round Table
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Phase 2 Multi-Institutional Study of Nivolumab for Patients with Advanced Refractory Biliary Tract Cancer  
    Olatunji B Alese, Daneng Li, Amit Mahipal, JAMA Oncology

Lectures

  • A phase II study of niraparib in combination with EGFR inhibitor panitumumab in patients with advanced colorectal cancer. 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
  • Perioperative therapy in patients with metastatic colorectal cancer. 
    2019 ASCO Annual Meeting - 6/1/2019
  • A phase I/II study of trifluridine/tipiracil (TAS-102) in combination with nanoliposomal irinotecan (NAL-IRI) in advanced GI cancers. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Authored Content

  • A Phase 2 Multi-Institutional Study of Nivolumab for Patients with Advanced Refractory Biliary Tract CancerMay 2020
  • A Phase 2 Multi-Institutional Study of Nivolumab for Patients with Advanced Refractory Biliary Tract CancerMay 2020

Press Mentions

  • Rise in Colon Cancer Among Young People, African Americans, Cause for Concern
    Rise in Colon Cancer Among Young People, African Americans, Cause for ConcernApril 27th, 2023
  • Emory’s Winship Cancer Institute Works to Bridge Racial Disparities in Cancer
    Emory’s Winship Cancer Institute Works to Bridge Racial Disparities in CancerJuly 18th, 2022
  • Expert Faults Poor Cancer Care in Nigeria
    Expert Faults Poor Cancer Care in NigeriaOctober 10th, 2015

Grant Support

  • Translational Physician-Scientist Training Program in OncologyNational Cancer Institute (NCI)Present
  • Nell W. and William Simpson Elkin Cancer Research FellowshipWinship Cancer InstitutePresent
  • International Cancer Technology Transfer Fellowship (ICRETT)Union for International Cancer Control (UICC)Present
  • Paul Carbone, MD Fellowship GrantEastern Cooperative Oncology Group (ECOG-ACRIN)Present
  • Faculty Start-Up Research FundWinship Cancer InstitutePresent

Professional Memberships